Examining the Molecular Profile of Responders & Non-Responders to Segment Heterogenous Disease Populations
Time: 1:15 pm
day: Day One
Details:
- Examining the molecular and cellular changes in patients who respond to therapy and secondary changes that occur beyond the immediate impact of the drug to reveal critical insights into disease mechanisms and therapeutic efficacy
- Exploring retrospective analysis to uncover predictive biomarkers and how these can enhance confidence in therapeutic decisions and patient stratification improving patient outcomes
- Analysis of molecular changes in non-responders compared to responders to uncover insights into potential treatment gaps and the need for additional or alternative therapies
